Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples